INNOTOX 50U

Innotox 50 Units: The Pinnacle of Botulinum Toxin Innovation

Innotox 50 Units represents a groundbreaking achievement in the world of aesthetic enhancements. Developed by South Korean company Medytox Inc., it has garnered immense popularity in clinics throughout South Korea and Japan, thanks to several remarkable advantages.

Revolutionary Structure and Composition

1. Liquid Phase Formula: Innotox shatters convention with its innovative liquid phase structure. This unique feature eliminates the need for time-consuming dilution. Each bottle contains a ready-made solution, providing 50 units of this remarkable product.

2. Advanced Formula: Innotox distinguishes itself with an improved formula. Notably, it lacks certain components that are present in other similar drugs, such as proteins, albumin, and gelatin. This sets it apart as a purer and more advanced solution.

Stability Under Various Conditions

3. Temperature Insensitivity: Innotox displays an impressive resistance to temperature fluctuations. Unlike its solid-phase counterparts, it remains stable under varying conditions. While storing it in a refrigerator is recommended, once opened, it can be safely kept at temperatures ranging from 2 to 8 degrees Celsius for 72 hours.

Efficiency and Longevity

4. Minimal Diffusion: Among all known botulinum toxins, Innotox boasts the least diffusion. This ensures precise and targeted treatment, reducing the risk of unintended effects.

5. Extended Effect: One of the most compelling features of Innotox is its long-lasting impact. While other botulinum toxins often provide results for up to four months, Innotox's effects endure for as long as eight months, providing patients with a more extended period of youthful and rejuvenated skin.

The Key Ingredients

Innotox's effectiveness is driven by its powerful components:

• Botulinum Toxin Type A
• L-methionine
• Polysorbate 20
• Buffered Saline Phosphate at pH 7.0

Versatile Applications

Innotox 50 Units addresses a range of concerns and is indicated for:

• Blepharospasm
• Hemifacial spasm
• Cervical dystonia (spastic torticollis)
• Focal spasticity of the wrist and hand in stroke patients
• Paralytic strabismus (squint)
• Local muscle spasm in cerebral palsy patients aged 2 and older
• Correction of facial wrinkles

Understanding Contraindications and Precautions

While Innotox is a remarkable product, it's crucial to be aware of its contraindications and potential side effects. Injections of Innotox should not be administered in cases of:

• Hypersensitivity to the product's components
• Pregnancy and lactation
• Inflammatory skin conditions in the target area
• Bleeding disorders
• Active herpes or any infectious and chronic systemic diseases in the acute stage
• Fever
• Diabetes
• Oncological diseases
• Pronounced hernial protrusions on the lower and upper eyelids
• Myasthenia gravis, an autoimmune disease causing chronic muscle fatigue syndrome
• Age under 18 or over 65 years

Expert Application

Innotox 50 Units should be administered by a qualified physician who has undergone appropriate training. A 30G needle is used to inject the solution at a rate of 4 units per 0.1 ml, regardless of the syringe's volume.